Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xueqing Tang, Hua Zheng, Haiyun Wang, Peng Xia, Ying Wang, Xue Zhao, Zijuan Zhou, Ling Qiu, Xuemei Li & Limeng Chen. (2022) Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study. Renal Failure 44:1, pages 336-345.
Read now
Read now
Articles from other publishers (3)
Hisao Otsuki & Junichi Yamaguchi. (2023) Intact Parathyroid Hormone in Hemodialysis Patients Undergoing Percutaneous Coronary Intervention ― Is It Just a Marker or a Diamond in the Rough? ―. Circulation Journal 87:2, pages 256-257.
Crossref
Crossref
Ahmed A. Hasan, Carl-Friedrich Hocher, Burkhard Kleuser, Bernhard K. Krämer & Berthold Hocher. (2022) Biological Activity of Different Forms of Oxidized Parathyroid Hormone. International Journal of Molecular Sciences 23:20, pages 12228.
Crossref
Crossref
Wang Guo, Huixian Zhang, Yamei Zhang, Hongdong Huang, Wenhu Liu & Zongli Diao. (2022) Low Parathyroid Hormone Versus Secondary Hyperparathyroidism and Survival in Patients Undergoing Hemodialysis: A Propensity-Matched Analysis. Frontiers in Endocrinology 13.
Crossref
Crossref